Concepedia

Ligia Chialda

LC

Statistics

Publications

5

Citations

418

H-Index

5

Active since

2005

Affiliations

AstraZeneca (Sweden)(Current)

PAREXEL International (United Kingdom)

Northwick Park Hospital

AstraZeneca (Netherlands)

Ligia Chialda is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and pharmacokinetics.

Publications per year

2005–2019

5

Publications

5

Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes

Li‐Ming Gan, Maria Lagerström‐Fermér, Leif Carlsson et al. · Nature Communications · 2019 · 215 citations · Full text

Medicine, Endocrinology, Molecular Medicine +13

Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustained, Exposure‐Dependent Reduction in Neutrophil Elastase Activity in Healthy Subjects

Robert S. Palmer, Jukka Mäenpää, Alexandra Jauhiainen et al. · Clinical Pharmacology & Therapeutics · 2018 · 98 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Inhibitors of mitogen-activated protein kinases differentially regulate costimulated T cell cytokine production and mouse airway eosinophilia

Ligia Chialda, Meixia Zhang, Kay Brune et al. · Respiratory Research · 2005 · 55 citations · Full text

Life Sciences, Immunology, Pathology +17

Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator

Fredrik Erlandsson, Muna Albayaty, Ligia Chialda et al. · British Journal of Clinical Pharmacology · 2018 · 28 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Initial Clinical Experience with AZD5718, a Novel Once Daily Oral 5‐Lipoxygenase Activating Protein Inhibitor

Hans Ericsson, Karin Nelander, Maria Lagerström‐Fermér et al. · Clinical and Translational Science · 2018 · 22 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

1–5 of 5